MPRI ARCTIC FRONT ADVANCE® CARDIAC CRYOABLATION CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
|
Back to Search Results |
|
Model Number 2AF284 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Low Blood Pressure/ Hypotension (1914); Cardiac Perforation (2513); Pericardial Effusion (3271)
|
Event Date 03/18/2024 |
Event Type
Injury
|
Event Description
|
It was reported that during a cryo ablation procedure, the patient had low blood pressure and a pericardial effusion.The case was aborted while the patient was under general anesthesia.A pericardiocentesis was performed. no further patient complications have been reported as a result of this event.
|
|
Manufacturer Narrative
|
Continuation of d10: product id: 990063-020, product type: mapping catheter.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Manufacturer Narrative
|
Continuation of d10: product id: 4fc12 product type: sheath product event summary: the patient data files and the (b)(6) balloon catheter with lot number 10241 was returned and analyzed.One patient file was received and recorded on the reported date of the event.The patient file showed eight applications were performed using a (b)(6) catheter with lot number 10241.The patient file also showed system notice 50012 (the refrigerant delivery path is obstructed) during the transition phase at application number one.No anomalies were identified during external visual inspection of the balloon, shaft, and handle segments.The catheter smart chip data was downloaded and reviewed.The data indicated the catheter was used for eight applications on the reported event date.The catheter was recognized and passed the electrical integrity verifications and performance test.The catheter completed the inflation, ablation, and thawing phases with no console system notices generated.No performance issues were identified.All pressure and flow values were in range and the temperature curve had no oscillations or overshoots.In conclusion, the clinical issues of perforation, pericardial effusion, and hypotension occurred during the procedure and the decision to abort the procedure without use of alternate therapy was based upon the medical judgement of the physician.There is no indication of a relation of the adverse event to the performance or malfunction of the product.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
It was later reported that the patient had a small baseline effusion and low blood pressure coming into the procedure.It was also reported that due to unstable blood pressure, there was a concern that the effusion may have been growing due to a perforation.After attempting pericardiocentesis, it was surmised that the patient did not have an actively bleeding perforation of growing effusion.
|
|
Search Alerts/Recalls
|
|
|